Cancer Core Europe: Leveraging Institutional Synergies to Advance Oncology Research and Care Globally-Reference-Cited by-同舟云学术

Cancer Core Europe: Leveraging Institutional Synergies to Advance Oncology Research and Care Globally

Published:2024-07-01 Issue:7 Volume:14 Page:1147-1153
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:

Author:

Carmona Javier¹^ORCID,Chavarria Elena¹^ORCID,Donoghue Kate²^ORCID,von Gertten Christina³^ORCID,Oberrauch Petra⁴⁵^ORCID,Pailler Emma⁶^ORCID,Scoazec Giovanni⁷^ORCID,Weijer Ruud⁸^ORCID,Balmaña Judith¹⁹^ORCID,Brana Irene¹⁹^ORCID,Brunelli Cinzia¹⁰^ORCID,Delaloge Suzette¹¹^ORCID,Deloger Marc⁶^ORCID,Delpy Pierre¹²¹³¹⁴^ORCID,Ernberg Ingemar¹⁵^ORCID,Fitzgerald Rebecca C.¹⁶^ORCID,Garralda Elena¹⁹^ORCID,Lablans Martin¹²¹³¹⁴^ORCID,Lëhtio Janne¹⁷¹⁸^ORCID,Lopez Carlos¹^ORCID,Fernández Maialen¹^ORCID,Miceli Rosalba¹⁹^ORCID,Nuciforo Paolo¹^ORCID,Perez-Lopez Raquel¹^ORCID,Provenzano Elena²^ORCID,Schmidt Marjanka K.²⁰^ORCID,Serrano Cesar¹⁹^ORCID,Steeghs Neeltje²¹^ORCID,Tamborero David¹⁷¹⁸^ORCID,Wirta Valtteri²²²³^ORCID,Baird Richard D.²^ORCID,Barker Karen²^ORCID,Barlesi Fabrice⁶²⁴^ORCID,Baumann Michael⁴⁵²⁵^ORCID,Bergh Jonas³²⁶^ORCID,de Braud Filippo⁷^ORCID,Fizazi Karim⁶^ORCID,Fröhling Stefan⁴⁵²⁵²⁷^ORCID,Piris-Giménez Alejandro¹^ORCID,Seamon Kenneth²^ORCID,Van der Heijden Michiel S.⁸^ORCID,Zwart Wilbert⁸²⁸^ORCID,Tabernero Josep¹⁹^ORCID

Affiliation:

1. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. 1

2. Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom. 2

3. Karolinska Institutet, Stockholm, Sweden. 3

4. German Cancer Research Center (DKFZ), Heidelberg, Germany. 4

5. National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany. 5

6. Gustave Roussy, Villejuif, France. 6

7. Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. 7

8. Netherlands Cancer Institute, Amsterdam, the Netherlands. 8

9. Department of Medical Oncology, Vall d’Hebron University Hospital, Barcelona, Spain. 9

10. Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. 10

11. Interception Programme, Department of Cancer Medicine, Gustave Roussy, Villejuif, France. 11

12. Federated Information Systems, German Cancer Research Center (DKFZ), Heidelberg, Germany. 12

13. Complex Medical Informatics, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany. 13

14. German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany. 14

15. Department of Microbiology, Tumor and Cell Biology (MTC), Cancer Center Karolinska (CCK) & Biomedicum. Karolinska Institutet, Stockholm, Sweden. 15

16. Department of Oncology, Early Cancer Institute, University of Cambridge, Cambridge, United Kingdom. 16

17. Department of Oncology and Pathology, Karolinska Institutet, SciLifeLab, Solna, Sweden. 17

18. Karolinska University Hospital, Stockholm, Sweden. 18

19. Unit of Biostatistics for Clinical Research, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. 19

20. Division of Molecular Pathology, NKI Center for Early Diagnostics, Lead Early Detection Research Theme, Netherlands Cancer Institute, Amsterdam, the Netherlands. 20

21. Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. 21

22. Department of Microbiology, Tumor and Cell Biology, Karolinska Instiutet, Stockholm, Sweden. 22

23. Genomic Medicine Center Karolinska, Karolinska University Hospital, Stockholm, Sweden. 23

24. Paris Saclay University, Villejuif, France. 24

25. German Cancer Consortium (DKTK), Heidelberg, Germany. 25

26. Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Solna, Sweden. 26

27. Institute of Human Genetics, Heidelberg University, Heidelberg, Germany. 27

28. Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands. 28

Abstract

Summary: Cancer Core Europe brings together the expertise, resources, and interests of seven leading cancer institutes committed to leveraging collective innovation and collaboration in precision oncology. Through targeted efforts addressing key medical challenges in cancer and partnerships with multiple stakeholders, the consortium seeks to advance cancer research and enhance equitable patient care.

Publisher

American Association for Cancer Research (AACR)

Link

https://aacrjournals.org/cancerdiscovery/article-pdf/doi/10.1158/2159-8290.CD-24-0377/3462026/cd-24-0377.pdf

Reference15 articles.

1. Cancer Core Europe: a consortium to address the cancer care-cancer research continuum challenge;Eggermont;Eur J Cancer,2014

2. Caring for patients with cancer in the COVID-19 era;van de Haar;Nat Med,2020

3. Early phase clinical trials in oncology: realising the potential of seamless designs;Jaki;Eur J Cancer,2023

4. Cancer Core Europe: a translational research infrastructure for a European mission on cancer;Eggermont;Mol Oncol,2019

5. Basket of baskets (BoB): a modular, open label, phase II, multicenter study to evaluate targeted agents in molecularly selected populations with advanced solid tumors;Brana;J Clin Oncol,2019